logo

BLUE’s Financial Health: Exploring Bluebird bio Inc’s Debt-to-Equity Ratio of 1.79

OPEN Stock

Bluebird bio Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $5.53 on 12/08/23, with the lowest value being $0.88 on 02/06/24.

52-week price history of BLUE Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Bluebird bio Inc’s current trading price is -79.02% away from its 52-week high, while its distance from the 52-week low is 31.97%. The stock’s price range for this period has remained between $0.88 and $5.53. The Healthcare sector company’s shares managed to surpass a trading volume of around 4.08 million for the day, which was noticeably lower compared to the shares’ average daily volume of 9.22 million over the last three months.

Financial Performance and Market Capitalization

Bluebird bio Inc (BLUE) has experienced a quarterly decline of -18.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 223.58M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8812, with a change in price of -1.8200. Similarly, Bluebird bio Inc recorded 11,246,841 in trading volume during the last 100 days, posting a change of -61.07%.

BLUE Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BLUE stands at 1.36. Similarly, the long-term debt-to-equity ratio is also 1.04.

BLUE Stock Stochastic Average

As of today, the raw stochastic average of Bluebird bio Inc over the past 50 days is 26.99%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 15.26%. Additionally, the Stochastic %K and %D values for the company were 23.17% and 23.54%, respectively, over the past 20 days.

BLUE Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -15.94%.However, over the last six months, we can see a stronger performance of -62.94%. Over the last 30 days, the price of BLUE has leaped by -20.00%. And in the last five days, it has fallen by -6.45%.